Diagnosis of Alzheimer's Disease

Archives of Neurology

Volumn 42, Issue 11, 1985, Pages 1097-1105

  Khachaturian, Zaven S ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER;

AGE; AGING; ALZHEIMER DISEASE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DEMENTIA; DIAGNOSIS; ETIOLOGY; HUMAN; PRIORITY JOURNAL; RESEARCH; REVIEW;

AGED; AGING; ALUMINUM; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; ELECTROPHYSIOLOGY; ENVIRONMENT; GENETICS; HUMAN; MIDDLE AGE; NEUROTRANSMITTERS; PEDIGREE; PSYCHOLOGICAL TESTS; RESEARCH; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0022414054     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1985.04060100083029     Document Type: Article

References (14)

1. National Institute on Aging Task Force Report: Senility reconsidered: Treatment possibilities for mental impairment in the elderly. JAMA 1980;244:259-263.
2. Yahr MD, Wolf A, Antunes JL, et al: Autopsy findings in parkinsonism following treatment with levodopa. Neurology 1972;22:56-71.
3. Chase GA, Folstein MF, Breitner JS, et al: The use of life tables and survival analysis in testing genetic hypotheses with an application to Alzheimer's disease. Am J Epidemiol 1983; 117:590-597.
4. Breitner JCS, Folstein MF: Familial Alzheimer dementia: A prevalent disorder with specific clinical features. Psychol Med 1984;14:63-80.
5. Martin WRW, Adam MJ, Ruth TJ, et al: The study of dopa metabolism in man with positron emission tomography. Neurology 1985;35:115.
6. Wooten GF, Ferrari MB: Compounds for imaging brain dopamine receptors in vivo. Neurology 1985;35:115.
7. Growdon JH, Corkin S, Buonano F, et al: Diagnostic methods in Alzheimer's disease: NMR brain imaging and CSF neurotransmitter markers, in Fisher A, Hanin I, Lachman C (eds): Alzheimer's and Parkinson's Disease: Strategies in Research and Development. New York, Plenum Press, in press.
8. Kay DWK: The epidemiology and identification of brain deficit in the elderly, in Eisdorfer C, Friedel RO (ed): Cognitive and Emotional Disturbance in the Elderly. Chicago, Year Book Medical Publishers Inc, 1977, pp 11-26.
9. Huff FJ, Maire JC, Growdon JH, et al: CSF cholinesterases in Alzheimer's disease. Neurology 1985;35:218.
10. Hanin I, Reynolds C, Kupfur DJ, et al: Elevated red blood cell plasma choline ratio in dementia of Alzheimer's type: Clinical and polysomnographic correlates. Psychiatry Res 1984;13:167-173.
11. Barclay LL, Kheyfets S, Zemcov A: Red cell plasma choline as marker of severity and genetic predisposition of Alzheimer disease. Neurology, in press.
12. Richardson AP: Congo red: Absorption, distribution, and sojourn in blood. Am J Med Sci 1939;198:87-94.
13. Richardson AP: Congo red: Hematologic actions. Am J Med Sci 1939;198:87-94.
14. Richardson AP, Dillon JR: Congo red: Toxicity and systemic actions. Am J Med Sci 1939; 198:73-82.